Physician profile
Thomas James Young
NPI 1033344866
$1,370.10
in general payments reported to CMS, 2019-2025
21 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.35 · 2020: $151 · 2021: $113 · 2022: $200 · 2023: $205 · 2024: $226 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $812.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $407.20 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Davol INC. | $208.97 | 2022-2025 | Phasix Mesh |
| Heron Therapeutics, INC. | $111.69 | 2023-2024 | Zynrelef |
| Medtronic, INC. | $100.18 | 2021-2025 | Signia |
| Smith+Nephew, INC. | $88.88 | 2019-2025 | Grafix Pl, Collagenase Santyl |
| Abbvie INC. | $75.49 | 2022-2023 | Dalvance |
| Hologic Sales and Service, LLC | $67.95 | 2023-2024 | Localizer |
| Kerecis Limited | $37.70 | 2020-2022 | |
| Abbott Laboratories | $37.60 | 2019-2023 | Cardiomems |
| Covidien LP | $33.29 | 2020 | |
| Solventum Corporation | $31.37 | 2024 | Activ.A.C., Snap, Promogran Prisma |
| Astrazeneca Pharmaceuticals LP | $21.87 | 2022 | |
| Olympus America INC. | $19.86 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.75 | 2021 | |
| Tei Medical INC. | $18.98 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $17.26 | 2020 | |
| Avanos Medical | $16.18 | 2025 | Initial Placement Kits |
| Biotronik INC. | $16.07 | 2019 | |
| Braintree Laboratories, INC. | $15.93 | 2023 | Sutab |
| Tetraphase Pharmaceuticals, INC. | $13.04 | 2019 | |
| Lifenet Health | $10.84 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.